Lieu P T, Heiskala M, Peterson P A, Yang Y
The R.W. Johnson Pharmaceutical Research Institute, 3210 Merryfield Row, San Diego, CA 92121, USA.
Mol Aspects Med. 2001 Feb-Apr;22(1-2):1-87. doi: 10.1016/s0098-2997(00)00006-6.
Iron is vital for almost all living organisms by participating in a wide variety of metabolic processes, including oxygen transport, DNA synthesis, and electron transport. However, iron concentrations in body tissues must be tightly regulated because excessive iron leads to tissue damage, as a result of formation of free radicals. Disorders of iron metabolism are among the most common diseases of humans and encompass a broad spectrum of diseases with diverse clinical manifestations, ranging from anemia to iron overload and, possibly, to neurodegenerative diseases. The molecular understanding of iron regulation in the body is critical in identifying the underlying causes for each disease and in providing proper diagnosis and treatments. Recent advances in genetics, molecular biology and biochemistry of iron metabolism have assisted in elucidating the molecular mechanisms of iron homeostasis. The coordinate control of iron uptake and storage is tightly regulated by the feedback system of iron responsive element-containing gene products and iron regulatory proteins that modulate the expression levels of the genes involved in iron metabolism. Recent identification and characterization of the hemochromatosis protein HFE, the iron importer Nramp2, the iron exporter ferroportin1, and the second transferrin-binding and -transport protein transferrin receptor 2, have demonstrated their important roles in maintaining body's iron homeostasis. Functional studies of these gene products have expanded our knowledge at the molecular level about the pathways of iron metabolism and have provided valuable insight into the defects of iron metabolism disorders. In addition, a variety of animal models have implemented the identification of many genetic defects that lead to abnormal iron homeostasis and have provided crucial clinical information about the pathophysiology of iron disorders. In this review, we discuss the latest progress in studies of iron metabolism and our current understanding of the molecular mechanisms of iron absorption, transport, utilization, and storage. Finally, we will discuss the clinical presentations of iron metabolism disorders, including secondary iron disorders that are either associated with or the result of abnormal iron accumulation.
铁通过参与多种代谢过程,包括氧气运输、DNA合成和电子传递,对几乎所有生物都至关重要。然而,由于自由基的形成,过量的铁会导致组织损伤,因此必须严格调节身体组织中的铁浓度。铁代谢紊乱是人类最常见的疾病之一,涵盖了广泛的疾病,临床表现多样,从贫血到铁过载,甚至可能包括神经退行性疾病。从分子层面理解身体中铁的调节对于确定每种疾病的潜在原因以及提供正确的诊断和治疗至关重要。铁代谢的遗传学、分子生物学和生物化学方面的最新进展有助于阐明铁稳态的分子机制。含铁反应元件的基因产物和铁调节蛋白的反馈系统紧密调节铁摄取和储存的协同控制,这些蛋白可调节参与铁代谢的基因的表达水平。最近对血色素沉着症蛋白HFE、铁转运蛋白Nramp2、铁输出蛋白铁转运蛋白1以及第二个转铁蛋白结合和转运蛋白转铁蛋白受体2的鉴定和表征,证明了它们在维持身体铁稳态中的重要作用。对这些基因产物的功能研究在分子水平上扩展了我们对铁代谢途径的认识,并为铁代谢紊乱的缺陷提供了有价值的见解。此外,多种动物模型已用于鉴定许多导致铁稳态异常的遗传缺陷,并提供了有关铁紊乱病理生理学的关键临床信息。在这篇综述中,我们讨论了铁代谢研究的最新进展以及我们目前对铁吸收、运输、利用和储存分子机制的理解。最后,我们将讨论铁代谢紊乱的临床表现,包括与铁异常积累相关或由其导致的继发性铁紊乱。
Mol Aspects Med. 2001
Semin Hematol. 2002-10
Antioxid Redox Signal. 2013-1-15
J Res Med Sci. 2014-2
Int J Biochem Cell Biol. 2001-10
Semin Liver Dis. 2011-9-7
Front Immunol. 2025-6-18
PLoS One. 2025-6-26
Int J Mol Sci. 2025-6-12
Infect Immun. 2025-6-10